Lido Advisors, LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 190 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lido Advisors, LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$131,057
-71.8%
11,211
-67.6%
0.00%
-66.7%
Q2 2023$465,400
-39.0%
34,628
-24.7%
0.00%
-57.1%
Q1 2023$762,614
+230.7%
45,996
+271.0%
0.01%
+133.3%
Q4 2022$230,621
+0.3%
12,399
-31.1%
0.00%0.0%
Q3 2022$230,000
+76.9%
17,996
-3.5%
0.00%
+50.0%
Q2 2022$130,000
-54.9%
18,653
-46.4%
0.00%
-33.3%
Q1 2022$288,000
+36.5%
34,831
+11.7%
0.00%
+50.0%
Q4 2021$211,000
-43.6%
31,176
-55.9%
0.00%
-60.0%
Q3 2021$374,000
+74.0%
70,636
+89.1%
0.01%
+66.7%
Q2 2021$215,000
-15.7%
37,353
-32.4%
0.00%
-25.0%
Q1 2021$255,000
+339.7%
55,284
+180.7%
0.00%
+300.0%
Q3 2020$58,000
-52.1%
19,692
-24.9%
0.00%
-75.0%
Q2 2020$121,000
+16.3%
26,204
-2.7%
0.00%0.0%
Q1 2020$104,000
-1.9%
26,924
-4.6%
0.00%0.0%
Q4 2019$106,000
-32.1%
28,216
-4.0%
0.00%
-50.0%
Q3 2019$156,000
-52.9%
29,392
-65.9%
0.01%
-57.9%
Q2 2019$331,000
-48.6%
86,304
-31.7%
0.02%
-54.8%
Q1 2019$644,000
+196.8%
126,403
+11.8%
0.04%
+100.0%
Q4 2018$217,000
-42.6%
113,023
+12.8%
0.02%
-43.2%
Q3 2018$378,000
+38.5%
100,205
+14.5%
0.04%
+19.4%
Q2 2018$273,000
+92.3%
87,506
+46.5%
0.03%
+63.2%
Q1 2018$142,00059,7400.02%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$1,902,0005.68%
GABLES CAPITAL MANAGEMENT INC. 433,814$5,566,0004.46%
Quantedge Capital Pte Ltd 503,700$6,462,0001.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,896,000$62,816,0001.25%
Lanham O'Dell & Company, Inc. 20,145$258,0000.92%
Capital Impact Advisors, LLC 59,301$907,0000.90%
SummerHaven Investment Management, LLC 98,840$1,268,0000.88%
Yorktown Management & Research Co Inc 50,000$642,0000.83%
GLOBEFLEX CAPITAL L P 304,293$3,904,0000.67%
AFFINITY INVESTMENT ADVISORS, LLC 90,864$1,166,0000.60%
View complete list of CATALYST PHARMACEUTICALS INC shareholders